XML 15 R4.htm IDEA: XBRL DOCUMENT v3.21.2
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Income Statement [Abstract]        
Revenue $ 192,230 $ 161,377 $ 559,845 $ 477,779
Expenses:        
Cost of revenue [1] 54,951 39,561 151,013 117,365
Sales and marketing [1] 21,098 14,898 62,306 45,130
Research and development [1] 9,569 7,941 27,437 23,880
General and administrative [1] 55,389 54,865 161,957 163,977
Depreciation and amortization 29,647 28,183 87,988 86,749
Impairment charge 2,954 0 2,954 0
Total operating expenses 173,608 145,448 493,655 437,101
Income from operations 18,622 15,929 66,190 40,678
Other income and (expenses):        
Interest income 69 50 166 436
Interest expense (12,999) (13,648) (38,991) (42,468)
Other expense, net (728) (332) (768) (502)
Income (Loss) before taxes 4,964 1,999 26,597 (1,856)
(Benefit from) Provision for income taxes (6,771) 1,175 (3,874) (3,022)
Net income 11,735 824 30,471 1,166
Net income attributable to common stockholders, basic 11,410 800 29,654 1,130
New income attributable to common stockholders, diluted $ 11,410 $ 800 $ 29,654 $ 1,130
Net income per share attributable to common stockholders, basic and diluted:        
Basic net income per share (in dollars per share) $ 0.08 $ 0.01 $ 0.20 $ 0.01
Diluted net income per share (in dollars per share) $ 0.08 $ 0.01 $ 0.20 $ 0.01
Weighted average shares of common stock outstanding:        
Basic (in shares) 150,873 149,720 150,624 149,474
Diluted (in shares) 150,952 149,903 150,728 149,650
[1]
(1)Includes stock-based compensation expense as follows: 
Cost of revenue$327 $156 $812 $474 
Sales and marketing1,259 717 3,333 2,089 
Research and development427 287 1,110 1,009 
General and administrative6,403 6,853 17,106 19,562 
Total stock-based compensation expense$8,416 $8,013 $22,361 $23,134